- Home
- VRDN vs SGRY Comparison
VRDN vs SGRY Comparison
Compare VRDN & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | SGRY |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | VRDN | SGRY |
|---|---|---|
| Price | $31.17 | $15.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $40.45 | $27.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $70,789,000.00 | ★ $3,288,100,000.00 |
| Revenue This Year | $26,257.62 | $7.76 |
| Revenue Next Year | $10.69 | $8.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23340.07 | 10.14 |
| 52 Week Low | $9.90 | $14.94 |
| 52 Week High | $34.04 | $26.16 |
Technical Indicators
Market Signals| Indicator | VRDN | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 37.20 |
| Support Level | $30.57 | $15.21 |
| Resistance Level | $32.92 | $16.03 |
| Average True Range (ATR) | 0.98 | 0.45 |
| MACD | -0.39 | 0.08 |
| Stochastic Oscillator | 19.02 | 19.41 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.